Suchergebnisse - "Ko, Andrew H"

PubPharm (177)

1

A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer

enthalten in: Investigational new drugs | 2024

von Ko, A. | Coveler, A. | Schlechter, B. | +9

2

A multicenter phase Ia study of AbGn-107, a novel antibody–drug conjugate, in patients with advanced gastrointestinal cancer

enthalten in: Investigational new drugs | 2024

von Ko, A. | Coveler, A. | Schlechter, B. | +9

3

Flashback Foreword : Gemcitabine for Advanced Pancreatic Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von O'Reilly, E. | Ko, A. | Friedberg, J.

4

Hyperpolarized 13 C Metabolic MRI of Patients with Pancreatic Ductal Adenocarcinoma

enthalten in: Journal of magnetic resonance imaging : JMRI | 2023

von Gordon, J. | Chen, H. | Nickles, T. | +7

5

Flashback Foreword : Erlotinib and Gemcitabine in Pancreatic Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Ko, A.

6

Maintenance Treatment for Metastatic Pancreatic Cancer : Balancing Therapeutic Intensity with Tolerable Toxicity

enthalten in: Cancers | 2023

von Walker, E. | Ko, A.

7

Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2023

von Chiorean, E. | Chiaro, M. | Tempero, M. | +36

8

Flashback Foreword : KRAS Is a Selection Marker for Panitumumab Benefit in Patients With Metastatic Colorectal Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Ko, A.

9

Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer : MORPHEUS Phase Ib/II Umbrella Randomized Study Platform

enthalten in: The oncologist | 2023

von Ko, A. | Kim, K. | Siveke, J. | +17

10

Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma : Results From a Randomized, Open-Label, Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Tempero, M. | Pelzer, U. | O'Reilly, E. | +129

CommentIn: J Clin Oncol. 2023 Apr 10;41(11):1972-1975. - PMID 36854094

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]